Raymond James Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.5B Sell
10,238,839
-120,066
-1% -$28M 0.77% 14
2025
Q4
$2.14B Buy
10,358,905
+221,254
+2% +$43.8M 0.67% 20
2025
Q3
$1.88B Buy
10,137,651
+690,887
+7% +$118M 0.6% 23
2025
Q2
$1.44B Sell
9,446,764
-21,350
-0.2% -$3.28M 0.5% 24
2025
Q1
$1.57B Buy
9,468,114
+203,291
+2% +$31.8M 0.59% 22
2024
Q4
$1.34B Buy
+9,264,823
New +$1.44B 0.49% 28

Other funds holding JNJ

Raymond James Financial's JNJ Position: Q1 2026 in Review

Raymond James Financial reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q1 2026, selling an estimated $28M and leaving 10,238,839 shares worth $2.5B. The position accounts for 0.77% of the portfolio, ranked #14.

Raymond James Financial first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,627 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Raymond James Financial held 10,238,839 shares of Johnson & Johnson worth $2.5B as of Q1 2026.
  • Raymond James Financial sold 120,066 Johnson & Johnson shares in Q1 2026, an estimated $28M.
  • Johnson & Johnson made up 0.77% of Raymond James Financial's portfolio in Q1 2026, its #14 holding.
  • Raymond James Financial first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,627 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.